Reaction Details |
| Report a problem with these data |
Target | Beta-adrenergic receptor kinase 1 |
---|
Ligand | BDBM50554258 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2048915 (CHEMBL4703614) |
---|
IC50 | 19±n/a nM |
---|
Citation | Xu, G; Gaul, MD; Liu, Z; DesJarlais, RL; Qi, J; Wang, W; Krosky, D; Petrounia, I; Milligan, CM; Hermans, A; Lu, HR; Huang, DZ; Xu, JZ; Spurlino, JC Hit-to-lead optimization and discovery of a potent, and orally bioavailable G protein coupled receptor kinase 2 (GRK2) inhibitor. Bioorg Med Chem Lett30:0 (2020) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Beta-adrenergic receptor kinase 1 |
---|
Name: | Beta-adrenergic receptor kinase 1 |
Synonyms: | ADRBK1 | ARBK1_HUMAN | BARK | BARK1 | Beta-ARK-1 | Beta-adrenergic receptor kinase 1 | G-protein coupled receptor kinase 2 | G-protein coupled receptor kinase 2 (GRK2) | GRK2 |
Type: | Enzyme |
Mol. Mass.: | 79581.30 |
Organism: | Homo sapiens (Human) |
Description: | P25098 |
Residue: | 689 |
Sequence: | MADLEAVLADVSYLMAMEKSKATPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFS
QKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLAC
SHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNV
ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER
IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE
IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE
VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE
LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAA
DAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEARK
KAKNKQLGHEEDYALGKDCIMHGYMSKMGNPFLTQWQRRYFYLFPNRLEWRGEGEAPQSL
LTMEEIQSVEETQIKERKCLLLKIRGGKQFILQCDSDPELVQWKKELRDAYREAQQLVQR
VPKMKNKPRSPVVELSKVPLVQRGSANGL
|
|
|
BDBM50554258 |
---|
n/a |
---|
Name | BDBM50554258 |
Synonyms: | CHEMBL4744858 |
Type | Small organic molecule |
Emp. Form. | C19H16N4O2 |
Mol. Mass. | 332.3559 |
SMILES | COc1cccc(Cn2ncc3ccc(cc3c2=O)-c2cn[nH]c2)c1 |
Structure |
|